Patient-reported outcomes in patients with and without resolution of PN symptoms
| EORTC QLQ-C30 score, median (IQR) . | PN symptoms resolved (n = 35)∗ . | PN symptoms not resolved (n = 14)† . |
|---|---|---|
| Global health status/QOL | ||
| Baseline | 66.7 (47.9-83.3) | 50.0 (33.3-66.7) |
| First time point after PN symptom resolution | 66.7 (50.0-83.3) | |
| Final | 75.0 (66.7-87.5) | 54.2 (50.0-66.7) |
| Pain | ||
| Baseline | 16.7 (0-33.3) | 16.7 (0-16.7) |
| First time point after PN symptom resolution | 16.7 (0-33.3) | |
| Final | 0 (0-33.3) | 50.0 (0-50.0) |
| Physical functioning | ||
| Baseline | 80.0 (65.0-93.3) | 66.7 (60.0-80.0) |
| First time point after PN symptom resolution | 86.7 (70.0-100) | |
| Final | 86.7 (76.7-100) | 66.7 (43.3-80.0) |
| EORTC QLQ-C30 score, median (IQR) . | PN symptoms resolved (n = 35)∗ . | PN symptoms not resolved (n = 14)† . |
|---|---|---|
| Global health status/QOL | ||
| Baseline | 66.7 (47.9-83.3) | 50.0 (33.3-66.7) |
| First time point after PN symptom resolution | 66.7 (50.0-83.3) | |
| Final | 75.0 (66.7-87.5) | 54.2 (50.0-66.7) |
| Pain | ||
| Baseline | 16.7 (0-33.3) | 16.7 (0-16.7) |
| First time point after PN symptom resolution | 16.7 (0-33.3) | |
| Final | 0 (0-33.3) | 50.0 (0-50.0) |
| Physical functioning | ||
| Baseline | 80.0 (65.0-93.3) | 66.7 (60.0-80.0) |
| First time point after PN symptom resolution | 86.7 (70.0-100) | |
| Final | 86.7 (76.7-100) | 66.7 (43.3-80.0) |
IQR, interquartile range.
Patients with PN symptom resolution who completed the EORTC QLQ-C30 questionnaire at baseline (n = 32), the first time point after PN symptom resolution (n = 31), and the final time point (n = 35).
Patients without PN symptom resolution who completed the EORTC QLQ-C30 questionnaire at baseline (n = 13) and the final time point (n = 14).